Abstract

Symptomatic hemorrhagic transformation (HT) is one of the complications most likely to lead to death in patients with acute ischemic stroke. HT after acute ischemic stroke is diagnosed when certain areas of cerebral infarction appear as cerebral hemorrhage on radiological images. Its mechanisms are usually explained by disruption of the blood-brain barrier and reperfusion injury that causes leakage of peripheral blood cells. In ischemic infarction, HT may be a natural progression of acute ischemic stroke and can be facilitated or enhanced by reperfusion therapy. Therefore, to balance risks and benefits, HT occurrence in acute stroke settings is an important factor to be considered by physicians to determine whether recanalization therapy should be performed. This review aims to illustrate the pathophysiological mechanisms of HT, outline most HT-related factors after reperfusion therapy, and describe prevention strategies for the occurrence and enlargement of HT, such as blood pressure control. Finally, we propose a promising therapeutic approach based on biological research studies that would help clinicians treat such catastrophic complications.

Highlights

  • Hemorrhagic transformation refers to hemorrhagic infarction that occurs after venous thrombosis or arterial thrombosis and embolism [1, 2]

  • The frequency of hemorrhagic transformation (HT) is associated with different factors, such as epidemiological factors, characteristics of the infarct, reperfusion techniques in the acute phase, radiological diagnosis (CT or magnetic resonance imaging (MRI) techniques), and use of antithrombotics after the acute phase [20,21,22]

  • This point can be influenced by the accuracy of imaging modalities used, such as computed tomography (CT) or MRI with or without gradient-echo or susceptibility-weighted sequences [65], which are more sensitive to the detection of blood products [64]

Read more

Summary

INTRODUCTION

Hemorrhagic transformation refers to hemorrhagic infarction that occurs after venous thrombosis or arterial thrombosis and embolism [1, 2]. Autopsy studies have reported an HT rate of 18–42% in acute ischemic stroke due to arterial occlusion [1, 3]. Prior to considering the frequency of occurrence of HT, we need to understand the imaging and clinical definitions of HT. Rates of HT in ischemic stroke have been reported, more than half of all cerebral infarctions demonstrate certain stages of HT [5]. On CT scans, the severity of HT is divided into two stages: hemorrhagic infarction (HI) and parenchymal hemorrhage (PH) with or without mass effect. With recent advances in intravenous [9] or endovascular [10] reperfusion therapies for acute ischemic stroke [11], stroke physicians need to deepen their understanding of cerebral hemorrhagic complications. The overall risks of complications have been well-documented in various

Confluent petechial bleeding within the infarcted area
MECHANISMS OF HT AFTER ISCHEMIC STROKE
FACTORS ASSOCIATED WITH HT AFTER ISCHEMIC STROKE
REVERSAL OF COAGULOPATHY WITH VARIOUS AGENTS
PREVENTION OF HT EXPANSION
Low risk
Young Female Normal weight Normothermia Normoglycemia Normotensive No
No No No
All sICH patients
Risk of thrombotic complications
BLOOD PRESSURE MANAGEMENT AFTER THROMBECTOMY FOR PREVENTING HT
MEDICAL TREATMENT AND NEUROSURGICAL CONSIDERATIONS
POTENTIAL THERAPEUTIC INTERVENTIONS ALONG WITH BIOLOGICAL RESEARCH ON HT
Findings
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.